Internal Medicine, Hematology & Oncology · Tamarac, FL
NPI
1548276140
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
7301 N University Dr Ste 105
Tamarac, FL, 33321
Phone (954) 748-2500
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
68,995 services
Medicare patients, 2024
136
Average age 74
Drug cost, 2024
$3.8M
866 prescriptions
Company payments, 2025
$0
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew M Schneider was code J1439 (injection, ferric carboxymaltose, 1 mg), 18,750 times for 12 patients. In total Andrew M Schneider billed 68,995 services in 81 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 18,750 | 12 | $0.87 | $16K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,250 | 20 | $0.09 | $110 |
| 85025 Blood Count | Office | 311 | 93 | $7.61 | $2,367 |
| 99213 Office E&M - Established | Office | 181 | 84 | $69.96 | $13K |
| 96367 Intravenous Infusion, Hydration | Office | 139 | 19 | $22.55 | $3,134 |
| 96413 Chemotherapy Administration | Office | 129 | 21 | $99.93 | $13K |
| 96372 Injection Administration | Office | 103 | 27 | $11.36 | $1,170 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 103 | 23 | $0.63 | $65.24 |
| 96365 Intravenous Infusion, Hydration | Office | 56 | 30 | $49.57 | $2,776 |
| 96417 Chemotherapy Administration | Office | 46 | 11 | $51.34 | $2,362 |
| 99214 Office E&M - Established | Office | 19 | 13 | $94.35 | $1,793 |
| 99232 Hospital E&M - Subsequent | Facility | 16 | 13 | $64.20 | $1,027 |
| 99203 Office E&M - New | Office | 15 | 15 | $77.87 | $1,168 |
By year: 2022 $454K for 45,635 services; 2023 $478K for 46,021 services; 2024 $1.2M for 68,995 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 311 | 93 | $7.61 | $2,367 |
Medicare prescription drug claims, 2024
In 2024, the drug Andrew M Schneider prescribed most often to Medicare patients was Retacrit (Epoetin Alfa-Epbx), with 109 prescriptions and refills. In total Andrew M Schneider wrote 866 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Retacrit Epoetin Alfa-Epbx | 109 | 109 | 42 | $124K |
| Prednisone Generic | 49 | 55 | 17 | $239 |
| Ibrance Palbociclib | 37 | 37 | Under 11 | $607K |
| Anastrozole Generic | 32 | 92 | 16 | $531 |
| Lenalidomide Generic | 29 | 29 | Under 11 | $380K |
| Venclexta Venetoclax | 26 | 26 | Under 11 | $368K |
| Abiraterone Acetate Generic | 26 | 26 | Under 11 | $134K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 24 | 24 | 19 | $579 |
| Ondansetron Hcl Generic | 22 | 22 | 15 | $185 |
| Procrit Epoetin Alfa | 22 | 22 | Under 11 | $64K |
| Levofloxacin Generic | 21 | 21 | 19 | $88.71 |
| Remicade Infliximab | 19 | 25 | Under 11 | $176K |
| Gabapentin Generic | 18 | 19 | 11 | $195 |
| Eliquis Apixaban | 18 | 26 | Under 11 | $15K |
| Imatinib Mesylate Generic | 17 | 17 | Under 11 | $4,207 |
Brand drugs: - claims; generic drugs: 467 claims; opioid claims: 47.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew M Schneider $0 (- in general payments such as food, travel and fees) from 6 companies.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.